Credential Qtrade Securities Inc. Seagen Inc. Transaction History

Credential Qtrade Securities Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 21, 2025	SELL	$127.59 - $203.08 $259,645 - $413,267	-2,035 Closed	0 $0
Q4 2022 Jul 21, 2025	SELL	$117.37 - $139.17 $21,948 - $26,024	-187 Reduced 8.42%	2,035 $262 Million
Q3 2022 Jul 21, 2025	BUY	$135.27 - $180.11 $12,580 - $16,750	93 Added 4.37%	2,222 $304 Million
Q2 2022 Jul 21, 2025	SELL	$108.81 - $179.33 $313,155 - $516,111	-2,878 Reduced 57.48%	2,129 $377 Million
Q1 2022 Jul 21, 2025	BUY	$119.61 - $157.85 $61,359 - $80,977	513 Added 11.42%	5,007 $721 Million
Q4 2021 Jul 21, 2025	BUY	$142.57 - $190.86 $640,709 - $857,724	4,494 New	4,494 $695 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

Stay updated on Credential Qtrade Securities Inc. with notifications on news.